Jacobs Levy Equity Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
2018
Q4
$56K Buy
2018
Q3
$134K Sell
2018
Q2
$203K Buy
2018
Q1
$63K Buy
2017
Q4
$61K Buy
2016
Q4
Sell
2016
Q3
$72K Sell
2016
Q2
$163K Sell
2016
Q1
$173K Buy
2015
Q1
Sell
2014
Q4
$107K Buy